ARCHIVES

NCAB Committee Submits Drafts Of QRA Policy Statement

This article is from The Cancer Letter archive.

Vol. 09 No. 27 | July 8, 1983

Download PDF Visit The Full Archive

Related Articles

In Brief: Richard Fisher Named Fox Chase President and CEO

August 2, 2013

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013

Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials

March 26, 2004

Antibody Targeting PD-L1 Shows Fast Tumor Shrinkage

May 31, 2013

IOM Reports Says HIPPA Privacy Rule Hinders Research, Doesn’t Protect Patient Privacy

February 6, 2009